name:-0.066320180892944
name:-0.035842895507812
name:-0.0058860778808594
ENDO PHARMACEUTICALS INC. Patent Filings

ENDO PHARMACEUTICALS INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ENDO PHARMACEUTICALS INC..The latest application filed is for "oxymorphone controlled release compositions".

Company Profile
6.40.65
  • ENDO PHARMACEUTICALS INC. - Malvern PA US
  • Endo Pharmaceuticals Inc - Malvern PA US
  • ENDO PHARMACEUTICALS INC. - Malvem PA US
  • Endo Pharmaceuticals Inc. -
  • Endo Pharmaceuticals Inc. - Chadds Ford PA
  • Endo Pharmaceuticals Inc. - Malverm PA US
  • Endo Pharmaceuticals Inc - Chadds Ford PA
  • Endo Pharmaceuticals, Inc. - PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Grant 11,389,443 - Ahdieh July 19, 2
2022-07-19
Oxymorphone Controlled Release Compositions
App 20210008063 - Kao; Huai-Hung ;   et al.
2021-01-14
Sustained release formulations of nalbuphine
Grant 10,406,106 - Baichwal , et al. Sept
2019-09-10
Vitamin B12 Nasal Spray And Method Of Use
App 20190216842 - FELLER; Theodore H. ;   et al.
2019-07-18
Sustained Release Formulations Of Nalbuphine
App 20190117576 - BAICHWAL; Anand R. ;   et al.
2019-04-25
Vitamin B.sub.12 nasal spray and method of use
Grant 10,251,908 - Feller , et al.
2019-04-09
Sustained release formulation of nalbuphine
Grant 10,172,798 - Baichwal , et al. J
2019-01-08
Oxymorphone Controlled Release Compositions
App 20180338967 - Kao; Huai-Hung ;   et al.
2018-11-29
Vitamin B.sub.12 nasal spray and method of use
Grant 10,052,344 - Feller , et al. August 21, 2
2018-08-21
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment
App 20180098985 - Ahdieh; Harry
2018-04-12
Crystalline, anhydrous forms of oxymorphone hydrochloride
Grant 9,926,328 - Fischer , et al. March 27, 2
2018-03-27
Sustained Release Formulation Of Nalbuphine
App 20180042852 - BAICHWAL; Anand R. ;   et al.
2018-02-15
Oxymorphone controlled release formulations
Grant 9,820,982 - Kao , et al. November 21, 2
2017-11-21
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Grant 9,789,103 - Ahdieh October 17, 2
2017-10-17
Crystalline, Anhydrous Forms Of Oxymorphone Hydrochloride
App 20170137433 - FISCHER; Andreas ;   et al.
2017-05-18
Sustained Release Formulation Of Nalbuphine
App 20160263035 - BAICHWAL; Anand R. ;   et al.
2016-09-15
Crystalline, anhydrous forms of oxymorphone hydrochloride
Grant 9,440,986 - Fischer , et al. September 13, 2
2016-09-13
Sustained release formulation of nalbuphine
Grant 9,351,938 - Baichwal , et al. May 31, 2
2016-05-31
Oxymorphone Controlled Release Compositions
App 20160136152 - Kao; Huai-Hung ;   et al.
2016-05-19
Urethral Anastomosis Device And Method
App 20160074041 - Wirtel, III; Anthony J.
2016-03-17
Chronotherapeutic dosage forms
Grant 9,278,076 - Baichwal , et al. March 8, 2
2016-03-08
Sustained release formulation of nalbuphine
Grant 9,186,330 - Baichwal , et al. November 17, 2
2015-11-17
Urethral Anastomosis Device And Method
App 20150250479 - Goldberg; Roger P. ;   et al.
2015-09-10
Urethral Anastomosis Device And Method
App 20150245839 - Wirtel, III; Anthony J. ;   et al.
2015-09-03
Urethral anastomosis device and method
Grant 9,050,163 - Goldberg , et al. June 9, 2
2015-06-09
Oxymorphone Controlled Release Formulations
App 20150011577 - Kao; Huai-Hung ;   et al.
2015-01-08
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment
App 20140329847 - Ahdieh; Harry
2014-11-06
Sustained Release Formulation Of Nalbuphine
App 20140315937 - Baichwal; Anand R. ;   et al.
2014-10-23
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Grant 8,808,737 - Ahdieh August 19, 2
2014-08-19
Pyridine derivatives
Grant 8,809,372 - Smith , et al. August 19, 2
2014-08-19
Pyrimido-pyridazinone Compounds And Methods Of Use Thereof
App 20140221315 - Venkatesan; Aranapakam ;   et al.
2014-08-07
Cyclohexylamines
App 20140213552 - Thompson; Scott Kevin ;   et al.
2014-07-31
Sustained release formulations of nalbuphine
Grant 8,771,732 - Baichwal , et al. July 8, 2
2014-07-08
Sustained release formulation of nalbuphine
Grant 8,765,175 - Baichwal , et al. July 1, 2
2014-07-01
Pyrimido-pyridazinone compounds and methods of use thereof
Grant 8,729,079 - Venkatesan , et al. May 20, 2
2014-05-20
Oxymorphone Controlled Release Formulations
App 20140134250 - Kao; Huai-Hung ;   et al.
2014-05-15
Cyclohexylamines
Grant 8,685,418 - Thompson , et al. April 1, 2
2014-04-01
Sustained release matrix systems for highly soluble drugs
Grant 8,679,535 - Baichwal , et al. March 25, 2
2014-03-25
Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
App 20140073782 - Smith; Roger A. ;   et al.
2014-03-13
Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis
App 20140051702 - Gupta; Sandeep ;   et al.
2014-02-20
Substituted Amino-Pyrimidine Derivatives
App 20140038952 - Smith; Roger Astbury ;   et al.
2014-02-06
Catheter Valve And Methods Of Using Same
App 20130324975 - Douglas; Peter F. ;   et al.
2013-12-05
Abuse-resistant Opioid Dosage Form
App 20130209561 - Kao; Huai-Hung ;   et al.
2013-08-15
Substituted Quinazoline And Pyrido-pyrimidine Derivatives
App 20130190492 - Smith; Roger Astbury ;   et al.
2013-07-25
Abuse-resistant Controlled-release Opioid Dosage Form
App 20130172382 - Caruso; Frank S. ;   et al.
2013-07-04
Substituted quinazoline and pyrido-pyrimidine derivatives
Grant 8,440,662 - Smith , et al. May 14, 2
2013-05-14
Cyclohexylamines
App 20130101667 - Thompson; Scott Kevin ;   et al.
2013-04-25
Imidazole Derivatives
App 20130085164 - Smith; Roger Astbury ;   et al.
2013-04-04
Pyridine Derivatives
App 20130085148 - Smith; Roger Astbury ;   et al.
2013-04-04
Pyrimido-pyridazinone Compounds And Methods Of Use Thereof
App 20130053346 - Venkatesan; Aranapakam ;   et al.
2013-02-28
Oxymorphone controlled release formulations
Grant 8,329,216 - Kao , et al. December 11, 2
2012-12-11
Oxymorphone controlled release formulations
Grant 8,309,122 - Kao , et al. November 13, 2
2012-11-13
Abuse-resistant Controlled-release Opioid Dosage Form
App 20120252832 - Caruso; Frank S. ;   et al.
2012-10-04
Urethral Anastomosis Device And Method
App 20120245606 - Goldberg; Roger P. ;   et al.
2012-09-27
Abuse-resistant Opioid Dosage Form
App 20120237603 - Kao; Huai-Hung ;   et al.
2012-09-20
Abuse-resistant Opioid Dosage Form
App 20120231075 - Kao; Huai-Hung ;   et al.
2012-09-13
Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
App 20120129851 - Smith; Roger Astbury ;   et al.
2012-05-24
Abuse-resistant Opioid Dosage Form
App 20110135731 - Kao; Huai-Hung ;   et al.
2011-06-09
Abuse-resistant Opioid Dosage Form
App 20110020444 - Kao; Huai-Hung ;   et al.
2011-01-27
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment
App 20100151027 - Ahdieh; Harry
2010-06-17
Oxymorphone Controlled Release Formulations
App 20090192183 - Kao; Huai-Hung ;   et al.
2009-07-30
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
App 20090124650 - Ahdieh; Harry
2009-05-14
Treatment of xerostomia
Grant 7,501,452 - Troha , et al. March 10, 2
2009-03-10
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
App 20080318993 - Ahdieh; Harry
2008-12-25
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
App 20080318994 - Ahdieh; Harry
2008-12-25
Oxymorphone Controlled Release Formulations
App 20080262013 - Kao; Huai-Hung ;   et al.
2008-10-23
Transdermal Delivery Form Disposal Systems and Methods
App 20080226702 - Goldberg; Alan Philip
2008-09-18
Abuse-resistant controlled-release opioid dosage form
App 20080069881 - Caruso; Frank S. ;   et al.
2008-03-20
Oxymorphone Controlled Release Formulations
App 20070134328 - Kao; Huai-Hung ;   et al.
2007-06-14
Treatment of xerostomia
App 20070128284 - Troha; Janice Mary ;   et al.
2007-06-07
Method for the treatment of urinary incontinence
Grant 7,087,619 - Caruso August 8, 2
2006-08-08
Method for treating non-neuropathic pain
App 20060147510 - Galer; Bradley Stuart
2006-07-06
Carbinols for the treatment of neuropathic dysfunction
Grant 6,825,217 - Carliss , et al. November 30, 2
2004-11-30
Oxymorphone controlled release formulations
App 20030157167 - Kao, Huai-Hung ;   et al.
2003-08-21
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
App 20030130297 - Kao, Huai-Hung ;   et al.
2003-07-10
Method for treating non-neuropathic pain
App 20030124174 - Galer, Bradley Stuart
2003-07-03
Method for the treatment of urinary incontinence
Grant 6,562,835 - Caruso May 13, 2
2003-05-13
Abuse-resistant controlled-release opioid dosage form
App 20030065002 - Caruso, Frank S. ;   et al.
2003-04-03
Abuse resistant pharmaceutical composition containing capsaicin
App 20030064122 - Goldberg, Michael ;   et al.
2003-04-03
Abuse-resistant opioid dosage form
App 20030004177 - Kao, Huai-Hung ;   et al.
2003-01-02
Anticonvulsant containing composition for treating neuropathic pain
Grant 6,406,716 - Caruso , et al. June 18, 2
2002-06-18
Analgesic drug composition containing a capsaicinoid and potentiator therefor
Grant 6,277,398 - Caruso August 21, 2
2001-08-21
Process for manufacturing paroxetine solid dispersions
Grant 5,955,475 - Krape , et al. September 21, 1
1999-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed